Other Industries
Agilent stock plunge on weak guidance
Agilent Technologies (A) continued its year-long streak of beating analysts' earnings estimates and followed the same for the second quarter,…
Icahn, Deason dominate as Xerox abandons Fujifilm deal
Xerox (XRX) abandoned its proposed $6.1 billion deal with Fujifilm and agreed to hand over the company’s leadership to a…
Pfizer this year: Headwinds and tailwinds
Pfizer (PFE) is an interesting stock to follow. Apart from being a great dividend stock, the company also boasts of…
Dick’s Sporting Goods and gun companies part ways
Dick’s Sporting Goods (DKS) is losing allies over its new policies. Many large gun companies decided to end their association…
Mylan’s flagship EpiPen device is in shortage in the U.S.
Mylan’s (MYL) billion dollar emergency allergy treatment injector EpiPen is now being added to the list of medications in short…
Eli Lilly acquires ARMO Biosciences; strengthens oncology portfolio
Indianapolis-based pharma giant Eli Lilly (LLY) said it would acquire late-stage immune-oncology company ARMO Biosciences (ARMO) for $1.6 billion, or…
Tax benefits lift Mylan’s quarterly profit
Drug maker Mylan (MYL), mainly focused on the production of generic drugs, reported yet another quarter of declining sales, a…